Search
TYKERB 250 MG, Comprimé
Details
| --- | Description |
|---|---|
| Pack | Boîte de 70 |
| Strength (Dosage) | 250 MG |
| Laboratory | NOVARTIS PHARMA MAROC |
| Ingredients | Lapatinib |
| Therapeutic class | Antinéoplasique, inhibiteur de la tyrosine kinase |
| ATC code | L01XE07 |
| PPH | $1,097.10 |
| PPV | $1,118.20 |
| Refundable | Yes |
| Refund base | $1,118.20 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem